Cargando…

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry

BACKGROUND: Ischemic stroke/transient ischemic attack (TIA), major bleeding, and death are common outcomes in atrial fibrillation (AF) patients, so appropriate antithrombotic therapy is crucial. The objective of this study was to investigate the rate of ischemic stroke/TIA, major bleeding, and death...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krittayaphong, Rungroj, Winijkul, Arjbordin, Methavigul, Komsing, Sairat, Poom, investigators, C. O. O. L.-A. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885252/ https://www.ncbi.nlm.nih.gov/pubmed/35284003 http://dx.doi.org/10.1155/2022/5797257

Ejemplares similares

Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL‐AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
por: Winijkul, Arjbordin, et al.
Publicado: (2021)

Left Atrial Diameter in the Prediction of Thromboembolic Event and Death in Atrial Fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Predicting the Absolute Risk of Ischemic Stroke in Asian Patients with Atrial Fibrillation: Comparing the COOL-AF Risk Score with CARS/mCARS Models for Absolute Risk and the CHA2DS2-VASc Score
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Efficacy of R(2)CHA(2)DS(2)-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation
por: Methavigul, Komsing, et al.
Publicado: (2021)

Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study
por: Krittayaphong, Rungroj, et al.
Publicado: (2018)

History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score
por: Methavigul, Komsing, et al.
Publicado: (2023)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL‐AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin
por: Methavigul, Komsing, et al.
Publicado: (2019)

Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
por: Methavigul, Komsing
Publicado: (2022)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
por: Luengsupabul, Sirote, et al.
Publicado: (2020)

Safety and efficacy of non–vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation
por: Yamkasikorn, Janekij, et al.
Publicado: (2022)

Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry
por: Apiyasawat, Sirin, et al.
Publicado: (2021)

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
por: Beier, Lea, et al.
Publicado: (2022)

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
por: Mazurek, Michał, et al.
Publicado: (2017)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry
por: Sayın, Begüm Yetiş, et al.
Publicado: (2019)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
por: Pope, Marita Knudsen, et al.
Publicado: (2021)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
por: Apenteng, Patricia N, et al.
Publicado: (2018)

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry: Trends in antithrombotic therapy use in China
por: Liu, Xiaoxia, et al.
Publicado: (2023)

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
por: Huisman, Menno V., et al.
Publicado: (2016)

Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
por: Okumura, Yasuo, et al.
Publicado: (2017)

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation
por: Chu, Gordon, et al.
Publicado: (2020)

Time‐trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF‐STENT Registry
por: Boivin‐Proulx, Laurie‐Anne, et al.
Publicado: (2019)

Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry
por: Renda, Giulia, et al.
Publicado: (2020)

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
por: Kiliszek, Marek, et al.
Publicado: (2021)

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
por: Esato, Masahiro, et al.
Publicado: (2022)

Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation
por: Tzeis, Stylianos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jbclgdo136buhmqjsk193jvfu5